908 Devices Inc. (MASS) stock

MASSNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3028% above fair value

$9.74−0.05 (-0.51%)

Close on Nov 13, 2026Market cap $402.59MP/E –Yield –

908 Devices r&d expenses

Research and development expenses are spending on new products and technology.

908 Devices's R&D Expenses for the twelve months ending Sep 30, 2026 was $14.39M, down 9.9% year over year. For fiscal 2025 it was $15.58M, up 3.9% from the year before. The highest annual figure on record is $21.90M in fiscal 2023.

Annual r&d expenses

Period	Period end	Value	Change
FY2025	Dec 31, 2025	$15.58M	+3.9%
FY2024	Dec 31, 2024	$14.99M	-31.6%
FY2023	Dec 31, 2023	$21.90M	+25.0%
FY2022	Dec 31, 2022	$17.53M	+34.1%
FY2021	Dec 31, 2021	$13.07M	+58.7%
FY2020	Dec 31, 2020	$8.24M	–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q3 FY2026	Sep 30, 2026	$3.82M	-0.5%
Q2 FY2026	Jun 30, 2026	$3.60M	-18.3%
Q1 FY2026	Mar 31, 2026	$3.47M	-9.3%
Q4 FY2025	Dec 31, 2025	$3.50M	-10.2%
Q3 FY2025	Sep 30, 2025	$3.84M	-8.8%
Q2 FY2025	Jun 30, 2025	$4.41M	+22.7%
Q1 FY2025	Mar 31, 2025	$3.83M	+16.3%
Q4 FY2024	Dec 31, 2024	$3.90M	-28.4%
Q3 FY2024	Sep 30, 2024	$4.21M	-24.1%
Q2 FY2024	Jun 30, 2024	$3.59M	-35.0%
Q1 FY2024	Mar 31, 2024	$3.29M	-39.0%
Q4 FY2023	Dec 31, 2023	$5.44M	+16.8%
Q3 FY2023	Sep 30, 2023	$5.54M	+18.7%
Q2 FY2023	Jun 30, 2023	$5.53M	+28.7%
Q1 FY2023	Mar 31, 2023	$5.40M	+38.2%
Q4 FY2022	Dec 31, 2022	$4.66M	+24.5%
Q3 FY2022	Sep 30, 2022	$4.67M	+41.3%
Q2 FY2022	Jun 30, 2022	$4.29M	+40.5%
Q1 FY2022	Mar 31, 2022	$3.91M	+31.7%
Q4 FY2021	Dec 31, 2021	$3.75M	+64.1%
Q3 FY2021	Sep 30, 2021	$3.30M	+69.2%
Q2 FY2021	Jun 30, 2021	$3.06M	+65.5%
Q1 FY2021	Mar 31, 2021	$2.97M	+37.5%
Q4 FY2020	Dec 31, 2020	$2.28M	–
Q3 FY2020	Sep 30, 2020	$1.95M	–
Q2 FY2020	Jun 30, 2020	$1.85M	–
Q1 FY2020	Mar 31, 2020	$2.16M	–